Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Dina

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 7, 2011
A novel treatment strategy for ovarian cancer based on immunization against zona pellucida protein (ZP) 3Nafis A Rahman, Herjan J T Coelingh Bennink, Marcin Chrusciel, et al.
Cancer Research|May 17, 2011
HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancerEuan A Stronach, Albandri Alfraidi, Nona Rama, et al.
Cancers|December 11, 2022
Point-of-Care Diagnosis of Endometrial Cancer Using the Surgical Intelligent Knife (iKnife)-A Prospective Pilot Study of Diagnostic AccuracyDiana Marcus, David L Phelps, Adele Savage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Clinical Use of Programmed Cell Death-1 and Its Ligand Expression as Discriminatory and Predictive Markers in Ovarian CancerJayanta Chatterjee, Wei Dai, Nor Haslinda Abd Aziz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Dynamic spectral imaging: improving colposcopyWilliam P Soutter, Emmanuel Diakomanolis, Deirdre Lyons, et al.
British Journal of Cancer|March 29, 2017
Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre studyDavid L Phelps, Jane V Borley, Kirsty J Flower, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2015
Dose-Finding Quantitative 18F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic MalignanciesHatice Gungor, Azeem Saleem, Syed Babar, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 7, 2011
A novel treatment strategy for ovarian cancer based on immunization against zona pellucida protein (ZP) 3Nafis A Rahman, Herjan J T Coelingh Bennink, Marcin Chrusciel, et al.
Cancer Research|May 17, 2011
HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancerEuan A Stronach, Albandri Alfraidi, Nona Rama, et al.
Cancers|December 11, 2022
Point-of-Care Diagnosis of Endometrial Cancer Using the Surgical Intelligent Knife (iKnife)-A Prospective Pilot Study of Diagnostic AccuracyDiana Marcus, David L Phelps, Adele Savage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Clinical Use of Programmed Cell Death-1 and Its Ligand Expression as Discriminatory and Predictive Markers in Ovarian CancerJayanta Chatterjee, Wei Dai, Nor Haslinda Abd Aziz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Dynamic spectral imaging: improving colposcopyWilliam P Soutter, Emmanuel Diakomanolis, Deirdre Lyons, et al.
British Journal of Cancer|March 29, 2017
Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre studyDavid L Phelps, Jane V Borley, Kirsty J Flower, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2015
Dose-Finding Quantitative 18F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic MalignanciesHatice Gungor, Azeem Saleem, Syed Babar, et al.
Pageof 5